Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2017 046 199.7 |
96 | EP file number | EAKZ | 17 84 4238.0 |
86 | WO file number | WAKZ | PCT/US2017/047892 |
97 | EP publication number | EPN | 3503895 |
87 | WO publication number | WPN | 2018039157 |
54 | Designation/title | TI | ANTIVIRALE PRODRUGS VON TENOFOVIR |
51 | IPC main class | ICM (ICMV) | C07F 9/6561 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/52 (2006.01), A61P 31/12 (2006.01) |
22 | DE application date | DAT | Aug 22, 2017 |
96 | EP application date | EAT | Aug 22, 2017 |
86 | WO application date | WAT | Aug 22, 2017 |
43 | Date of first publication | OT | Mar 1, 2018 |
| Date of publication of grant | PET | Sep 15, 2021 |
71/73 | Applicant/owner | INH | Idenix Pharmaceuticals LLC, Cambridge, MA, US; Merck Sharp & Dohme LLC, Rahway, NJ, US |
72 | Inventor | IN | DA COSTA, Daniel, 34570 Montarnaud, FR; DOUSSON, Cyril, B., 34800 Canet, FR; DUKHAN, David, 34000 Montpellier, FR; PAPARIN, Jean-Laurent, 34230 Vendemian, FR; RAHALI, Houcine, 30126 Saint Laurent des Arbres, FR; RAHEEM, Izzat, West Point Pennsylvania 19486, US |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201662379455 P Aug 25, 2016
|
| Due date | FT FG | Aug 31, 2025 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003503895A1 Searchable text:
EP000003503895A1 Original document:
EP000003503895B1 Searchable text:
EP000003503895B1 Original document:
WO002018039157 Searchable text:
WO002018039157 |
43 | Date of first publication | EVT | Mar 1, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Jul 3, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 20, 2024 (Show all update days)(Hide all update days)- Jul 20, 2024
- St.36: changed (technical change)
- Jul 13, 2024; Jun 13, 2024; May 2, 2024; Jul 14, 2023; Nov 10, 2022; Sep 30, 2022; Aug 18, 2022; Aug 4, 2022; Jun 28, 2022; Nov 10, 2021; Sep 7, 2021; Aug 26, 2021; Aug 15, 2019
- Historical data not available for this/these date(s)
- Jul 3, 2019
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 29, 2022 |
| Issue number | HN | 45 |
| Year | PJ | 2022 |
| Publication date | VT | Nov 10, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Idenix Pharmaceuticals LLC, Cambridge, MA, US; Merck Sharp & Dohme LLC, Rahway, NJ, US |
71/73 | Previous applicant/owner | INHF | Idenix Pharmaceuticals LLC, Cambridge, MA, US, Merck Sharp & Dohme Corp., Rahway, N.J., US |
| Date of update of the procedure | REGT | Nov 10, 2022 |